Umbilical Cord and Placentary Blood Storage for the Treatment of Blood Diseases in Brazil: the Third Bone Marrow Donor Facing New Technologies


Umbilical Cord and Placentary Blood Storage for the Treatment of Blood Diseases in Brazil: the Third Bone Marrow Donor Facing New Technologies


MONTEIRO NETO, A.U1, SILVA, G.V.M1, LIMA, D.N1, PONTES, M.G.A1, TAVARES, A.B1, ANJOS, F.B.R2.

Academics of Universidade Federal de Pernambuco1, Professor of Universidade Federal de Pernambuco²


International Journal of stem cell research

Contemporary medicine has had several advances when it comes to treating diseases such as leukemia. One of these innovations was the use of human stem cells, through bone marrow transplantation, because these cells have the capacity to originate new cells when stimulated. Currently, the use of hematopoietic stem cells is performed in the treatment of more than 80 blood diseases and is the most efficient method, of which we have access, in the highlighted scenario. However, there are still several obstacles to the use of bone marrow cells, given the difficulty of compatibility between the donor and the recipient of the transplant. Due to such impediment, it was then observed that umbilical cord and placenta blood have transplantable cells, albeit in limited numbers, but are more likely to be compatible with the patient that will be receiving such cells. The present study aimed to analyze the Brazilian situation regarding the collection, processing, storage and use of this type of blood, as well as to investigate, from public access data about health, the difficulties for its greater use in the treatment of blood diseases.


Keywords: Cellularity, Umbilical Cord, Stem Cells, Placenta, Blood, Transplant


Free Full-text PDF


How to cite this article:
MONTEIRO NETO, A.U, SILVA, G.V.M, LIMA, D.N, PONTES, M.G.A, TAVARES, A.B, ANJOS, F.B.R. Umbilical Cord and Placentary Blood Storage for the Treatment of Blood Diseases in Brazil: the Third Bone Marrow Donor Facing New Technologies. International Journal of Stem Cell Research. 2018, 1:2


References:

1. ABRALE. Cerca de 80 Doenças Hematológicas Podem Ser Tratadas Com Transplante de Medula Óssea. 2017. Disponível em: <https://www.abrale.org.br/abrale-noticias/242-cerca-de-80-doencas-diferentes-relacionadas-ao-sangue-podem-ser-tratadas-com-o-transplante-de-medula-ossea>. Acesso em: 14 de dezembro de 2017.
2. ABRALE. REDOME lança portal no Dia Mundial do Doador de Medula Óssea. Disponível em: <http://redome.inca.gov.br/ola-mundo-6/>. Acesso em 16 de abril de 2018.
3. ANVISA. Relatório de Avaliação dos Dados de Produção dos Bancos de Sangue de Cordão Umbilical e Placentário. Anos: 2010, 2013, 2014 e 2016. Disponíveis em: <http://portal.anvisa.gov.br/sangue/publicacoes>. Acesso em: 14 de dezembro de 2017.
4. Ballen, K.K.; Gluckman, E.; Broxmeyer, H.E. Umbilical cord blood transplantations: the first 25 years and beyond. Blood, 2013, 122.4: 491-198.
5. Izu, M. et al. Influence of obstetric and neonatal factors in cellularity and volume of the umbilical cord. Journal of Nursing UFPE on line-ISSN: 1981-8963, v. 7, n. 7, p. 4621-4626, 2013.
6. Mendes-Takao, M. R. et al. Private umbilical cord blood banks for family use, in Brazil: technical, legal and ethical issues for an implementation analysis. Rev. Bras. Hematol. Hemoter., v. 32, n. 4, p. 317-328, 2010.
7. Neves, S.A. Banco de Sangue de Cordão Umbilical e Placentário: Proposta de Sistema Híbrido Brasileiro. 2012. 105 f. Dissertação (Mestrado Acadêmico em Engenharia Biomédica) – Programa de Pós-Graduação em Engenharia Elétrica e Informática Industrial, Universidade Tecnológica Federal do Paraná, Curitiba, 2012.
8. Nunes, R.D.; Zandavalli, F.M. Association between maternal and fetal factors and quality of cord blood as a source of stem cells. Rev. Bras. Hematol. Hemoter., São Paulo, v. 37, n. 1, p. 38-42, fev. 2015.
9. Rodrigues, C.A. et al.Transplante de sangue de cordão umbilical – SCU. Rev. Bras. Hematol. Hemoter. [online]. v.32, p.08-12, 2010.
10. Bouzas, L.F.S. Transplante de medula óssea em pediatria e transplante de cordão umbilical. Medicina, Ribeirão Preto 241-263, julho/setembro 2000.
11. Cruz, L.E. et al. Sangue de cordão umbilical para uso autólogo ou grupo de pacientes especiais. Rev. Bras. Hematol. Hemoter., São Paulo, v. 31, p. 36-44, maio 2009.
12. Oliveira Silva, M., Tenório Leoi, L. (2010). Banco de sangue de cordão umbilical e placentário no Brasil. Ensaios e Ciência: Ciências Biológicas, Agrárias e da Saúde, 14 (2), 125-141.
13. Senegaglia, A.C. et al. Formação in vitro de túbulos capilares a partir de células de sangue de cordão umbilical humano com perspectivas para aplicação terapêutica. Rev Bras Cir Cardiovasc, São josé do Rio Preto, v. 23, n. 4. dez. 2008.